The estimated Net Worth of Jensen Margaret E Valeur is at least $2.05 Million dollars as of 2 November 2015. Jensen Valeur owns over 50,000 units of Retrophin stock worth over $3,500 and over the last 21 years Jensen sold RTRX stock worth over $2,046,000.
Jensen has made over 2 trades of the Retrophin stock since 2015, according to the Form 4 filled with the SEC. Most recently Jensen sold 50,000 units of RTRX stock worth $1,023,000 on 2 November 2015.
The largest trade Jensen's ever made was selling 50,000 units of Retrophin stock on 2 November 2015 worth over $1,023,000. On average, Jensen trades about 4,167 units every 0 days since 2003. As of 2 November 2015 Jensen still owns at least 50,000 units of Retrophin stock.
You can see the complete history of Jensen Valeur stock trades at the bottom of the page.
Jensen's mailing address filed with the SEC is C/O RETROPHIN, INC., 777 THIRD AVENUE, 22ND FL., NEW YORK, NY, 10017.
Over the last 12 years, insiders at Retrophin have traded over $26,547,782 worth of Retrophin stock and bought 585,006 units worth $5,991,663 . The most active insiders traders include Martin Shkreli, Ron Squarer, and Steve Aselage. On average, Retrophin executives and independent directors trade stock every 23 days with the average trade being worth of $1,651. The most recent stock trade was executed by Laura Clague on 23 November 2020, trading 7,500 units of RTRX stock currently worth $174,675.
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.
Retrophin executives and other stock owners filed with the SEC include: